These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 19338141

  • 1. A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T, Reyar S, Tiwari HK, Tippabhotla SK, Khuroo A, Thudi NR, Ahmed S, Raghuvanshi R.
    Arzneimittelforschung; 2009; 59(2):104-8. PubMed ID: 19338141
    [Abstract] [Full Text] [Related]

  • 2. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T, Rao Thudi N, Koundinya Tippabhotla S, Khuroo A, Marwah A, Kumar Shrivastav V, Tandon M, Raghuvanshi R, Biswal S.
    Clin Ther; 2007 Dec; 29(12):2677-84. PubMed ID: 18201583
    [Abstract] [Full Text] [Related]

  • 3. Bioequivalence evaluation of a fixed dose combination lamivudine + stavudine tablet with concurrent administration of lamivudine tablet and stavudine capsule in healthy volunteers.
    Chachad S, Lulla A, Malhotra G, Purandare S.
    Arzneimittelforschung; 2009 Dec; 59(10):537-40. PubMed ID: 19998583
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
    Marier JF, Dimarco M, Guilbaud R, Dodard C, Morelli G, Tippabhotla SK, Singla AK, Thudi NR, Monif T.
    J Clin Pharmacol; 2007 Nov; 47(11):1381-9. PubMed ID: 17962426
    [Abstract] [Full Text] [Related]

  • 5. A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects.
    Narang VS, Lulla A, Malhotra G, Purandare S.
    J Clin Pharmacol; 2005 Mar; 45(3):265-74. PubMed ID: 15703362
    [Abstract] [Full Text] [Related]

  • 6. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [Abstract] [Full Text] [Related]

  • 7. Nevirapine/lamivudine/stavudine as a combined-formulation tablet: bioequivalence study compared with each component administered concurrently under fasting condition.
    Monif T, Tippabhotla SK, Garg M, Singla AK, Vijan T.
    Int J Clin Pharmacol Ther; 2006 Jun; 44(6):276-83. PubMed ID: 16800100
    [Abstract] [Full Text] [Related]

  • 8. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study.
    Dos Reis Serra CH, Mori Koono EE, Kano EK, Schramm SG, Armando YP, Porta V.
    Clin Ther; 2008 May; 30(5):902-8. PubMed ID: 18555936
    [Abstract] [Full Text] [Related]

  • 9. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S, Filipe A, Neves R, Pinho C, Pedroso P, Castillo A, Trabelsi F.
    Arzneimittelforschung; 2011 May; 61(1):32-9. PubMed ID: 21355444
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH, Shin KH, Kim J, Lim KS, Kim KP, Kim JR, Cho JY, Shin SG, Jang IJ, Yu KS.
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [Abstract] [Full Text] [Related]

  • 11. Bioequivalence of two lamivudine tablet formulations.
    Santos-Magalhães NS, Pontes A, Cavalcante RM, Costa RM, Rangel FA, Guimarães MI, de Carvalho JN, de Souza SD, de Oliveira HM, Esteves IL, Ramalho MS, Vieira SL, Alves AJ.
    Arzneimittelforschung; 2001 Nov; 51(4):310-4. PubMed ID: 11367872
    [Abstract] [Full Text] [Related]

  • 12. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L.
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [Abstract] [Full Text] [Related]

  • 13. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]

  • 14. Bioequivalence study of two oral tablet formulations containing tenofovir disoproxil fumarate in healthy volunteers.
    Yerino GA, Halabe EK, Zini E, Feleder EC.
    Arzneimittelforschung; 2011 Jun; 61(1):55-60. PubMed ID: 21355446
    [Abstract] [Full Text] [Related]

  • 15. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S, Filipe A, Neves R, Desjardins I, Shink E, Castillo A.
    Arzneimittelforschung; 2010 Jun; 60(3):116-23. PubMed ID: 20422942
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.
    Hosseinipour MC, Corbett AH, Kanyama C, Mshali I, Phakati S, Rezk NL, van der Horst C, Kashuba AD.
    AIDS; 2007 Jan 02; 21(1):59-64. PubMed ID: 17148968
    [Abstract] [Full Text] [Related]

  • 17. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications.
    Kayitare E, Vervaet C, Ntawukulilyayo JD, Seminega B, Bortel V, Remon JP.
    Int J Pharm; 2009 Mar 31; 370(1-2):41-6. PubMed ID: 19059324
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct 31; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 19. A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand.
    Vanprapar N, Cressey TR, Chokephaibulkit K, Muresan P, Plipat N, Sirisanthana V, Prasitsuebsai W, Hongsiriwan S, Chotpitayasunondh T, Eksaengsri A, Toye M, Smith ME, McIntosh K, Capparelli E, Yogev R, IMPAACT P1056 Team.
    Pediatr Infect Dis J; 2010 Oct 31; 29(10):940-4. PubMed ID: 20453709
    [Abstract] [Full Text] [Related]

  • 20. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L, Jiang X, Huang L, Lan K, Wang H, Hu L, Ren J, Li X, Zou Q.
    Clin Ther; 2009 Oct 31; 31(10):2242-8. PubMed ID: 19922895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.